We invite you to join us for a seminar geared specifically toward drug development professionals. Regis is excited to host guest speaker, Dr. Evan B. Siegel for a special presentation on efficient
We invite you to join us for a seminar geared specifically toward drug development professionals. Regis is excited to host guest speaker, Dr. Evan B. Siegel for a special presentation on efficient regulatory strategies.
Enjoy a morning of coffee and chemistry with us at Regis Technologies’ Morton Grove facility. Limited seating is available. RSVP by March 15 to save your seat.
There are many pathways to take in moving discovery data and early drug development data into the clinic. Recognition of the regulatory pathways that will be most efficient, cost-effective, and time-sparing is critical in the choice of partner, consultants and staff as a great idea is brought into the practical world of exploratory and confirmatory patient treatment. This seminar will provide a framework for the types of datasets that will be of most interest and usefulness to regulators, and will present concrete examples of how sparse data can be leveraged towards success for a provisional small molecule or biologic product.
Meet Our Speaker
Dr. Evan B. Siegel founded Ground Zero Pharmaceuticals, Inc. (GZP) in 1999 from his consulting firm, Ground Zero Strategics, Ltd. He currently serves as its President and CEO and is also the Chairman of the Board. Prior to GZP Evan served as Consultant and CEO to OXO Chemie Inc., Vice President, Regulatory Affairs and Bioethics for Medical Science Systems, Inc. (now Interleukin Genetics), and Director of Regulatory Consulting Services and Principal Regulatory Scientist for Quintiles, Inc., North Carolina. Dr. Siegel has also held regulatory affairs and executive positions at Astra and Syntex and was a Toxicology Reviewer at the US Food and Drug Administration, as well as Supervising Toxicologist and Chief of Special Services at the State of California’s Food and Drug Branch, Department of Health Services.
We are excited to host guest speaker, Dr. Evan B. Siegel for this special presentation.
As the globe grapples with increasing challenges to sustaining “business as usual” in their enterprises, our team of Employment, Employee Benefits, Health and Privacy & Cybersecurity lawyers invite you to
As the globe grapples with increasing challenges to sustaining “business as usual” in their enterprises, our team of Employment, Employee Benefits, Health and Privacy & Cybersecurity lawyers invite you to join us for important and urgent guidance on a developing pandemic.
Over a ninety minute period, we will cover:
Developing strategies around remote work facilitation including:responsibilities to quarantined and/or sick employees; work from home arrangements and social distancing; absences from work, paid time off, sick leave; discrimination, harassment and retaliation concerns; the impact on health plans and savings accounts, as well as health and safety considerations.
Mitigating Privacy and Cybersecurity risk by examining: privacy issues in sharing personal information of employees, guests or customers with third parties, including government agencies, and guidelines for sharing personal information for COVID-19 response when the data was originally collected for a different purpose. We will also discuss whether, when and how to inform individual that your company has shared their personal information for public health purposes.
HIPAA compliance considerations including: reporting to public health authorities; informing individuals who may have been in contact with a patient; discussing COVID-19 cases with the media; performing data analytics; and heightened security awareness.
The first in a series of webinars, we will arm you with actionable information to keep your business moving forward and answer your most pressing questions as the situation continues to evolve and change at a rapid pace.